Marjolein M. Van Der Poel-Van Der Wal
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.
Journal: Bone marrow transplantation
Published: March 02, 2026
Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.
Journal: Communications medicine
Published: January 23, 2026
Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 12, 2025
Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 20, 2025
Distinct Effects of Autologous Hematopoietic Stem Cell Transplantation on T Cell Composition and Profile in Refractory Crohn's Disease.
Journal: Inflammatory bowel diseases
Published: September 05, 2025
Relapsed and refractory peripheral T-cell lymphoma; treatment, challenges and future perspectives.
Journal: Leukemia & lymphoma
Published: August 28, 2025
Treatment and outcome of breast implant-associated anaplastic large cell lymphoma: a population-based cohort study in the Netherlands.
Journal: Leukemia & lymphoma
Published: July 09, 2025
Cell-free DNA genomic and fragmentomic features for early outcome prediction in large B cell lymphoma.
Journal: Cell reports. Medicine
Published: June 30, 2025
Last Updated: 09/26/2026